Carrick Therapeutics
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
4
Funding Rounds
$345.0m
Money raised
Overview
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
- Website:
- Business model: B2C
- Headquarters: Dublin
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Carrick Therapeutics has raised a total of $345m in funding over 4 rounds.
Key Insights:
- Carrick Therapeutics December 2022 Series C Funding Round: $60m
- Carrick Therapeutics October 2016 Series A Funding Round: $95m
- Carrick Therapeutics October 2016 Series A Funding Round: $95m
- Carrick Therapeutics , October 2016: $95m
Carrick Therapeutics December 2022 Series C Funding Round
$60m
Carrick Therapeutics October 2016 Series A Funding Round
$95m
Carrick Therapeutics October 2016 Series A Funding Round
$95m
Carrick Therapeutics , October 2016
$95m
Industries
Carrick Therapeutics is active in the following industries: